Share This Article:

Synergistic Suppression of Cortical Spreading Depression under NR2A and NR2B Inhibition

Abstract Full-Text HTML XML Download Download as PDF (Size:643KB) PP. 573-579
DOI: 10.4236/pp.2015.612059    3,643 Downloads   4,018 Views   Citations

ABSTRACT

Cortical spreading depression (CSD) is a transient synaptic excitation, followed by depression, which can propagate slowly across cortex, subcortex and retina. CSD is implicated in migraine with aura and may lead to migraine pain. CSD can be suppressed by inhibition of both NR2A and NR2B containing N-methyl-D-aspartic acid (NMDA) receptors. However, whether there is a synergistic effect of co-inhibition of NR2A and NR2B containing receptors on CSD remains unknown. In this study, an efficient in vitro model of migraine with intrinsic optical imaging approach was applied to address this role of co-activation of both NR2A and NR2B in CSD. The results showed that co-application of NVP-AAM077, a drug selectively targeting for NR2A and Ro 25-6981, a drug selectively targeting for NR2B containing receptors, showed synergistic inhibitory effects on propagation rate and the magnitude of CSD in a concentration dependent manner in chick retina. Inhibition of CSD propagation was also observed by a clinical acceptable drug that antagonizes both NR2A and NR2B containing receptors, memantine, at 10 μM. These data suggest that combinational use of antagonists selectively targeting NR2A and NR2B containing receptors could be a useful strategy for preventative treatment of migraine with improved efficacy with potential alleviated side effects.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Jia, Y. , Zhou, J. , Bu, F. and Wang, M. (2015) Synergistic Suppression of Cortical Spreading Depression under NR2A and NR2B Inhibition. Pharmacology & Pharmacy, 6, 573-579. doi: 10.4236/pp.2015.612059.

References

[1] Hadjikhani, N., Sanchez Del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., et al. (2001) Mechanisms of Migraine Aura Revealed by Functional MRI in Human Visual Cortex. Proceedings of the National Academy of Sciences USA, 98, 4687-4692.
http://dx.doi.org/10.1073/pnas.071582498
[2] Moskowitz, M.A. (2007) Athophysiology of Headache—Past and Present. Headache, 47, S58-S63.
http://dx.doi.org/10.1111/j.1526-4610.2007.00678.x
[3] Russo, A.F. (2015) Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine. Annual Review of Pharmacology and Toxicology, 55, 533-552.
http://dx.doi.org/10.1146/annurev-pharmtox-010814-124701
[4] Karatas, H., Erdener, S.E., Gursoy-Ozdemir, Y., Lule, S., Eren-Kocak, E., Sen, Z.D., et al. (2013) Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels. Science, 339, 1092-1095.
http://dx.doi.org/10.1126/science.1231897
[5] Zhang, X., Levy, D., Kainz, V., Noseda, R., Jakubowski, M. and Burstein, R. (2011) Activation of Central Trigeminovascular Neurons by Cortical Spreading Depression. Annals of Neurology, 69, 855-865.
http://dx.doi.org/10.1002/ana.22329
[6] Zhang, X., Levy, D., Noseda, R., Kainz, V., Jakubowski, M. and Burstein, R. (2010) Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura. Journal of Neuroscience, 30, 8807-8814.
http://dx.doi.org/10.1523/JNEUROSCI.0511-10.2010
[7] Marrannes, R., Willems, R., De Prins, E. and Wauquier, A. (1988) Evidence for a Role of the N-Methyl-D-aspartate (NMDA) Receptor in Cortical Spreading Depression in the Rat. Brain Research, 457, 226-240.
http://dx.doi.org/10.1016/0006-8993(88)90690-7
[8] Wang, M., Chazot, P.L., Ali, S., Duckett, S.F. and Obrenovitch, T.P. (2012) Effects of NMDA Receptor Antagonists with Different Subtype Selectivities on Retinal Spreading Depression. British Journal of Pharmacology, 165, 235-244.
http://dx.doi.org/10.1111/j.1476-5381.2011.01553.x
[9] Shi, H., Li, J.H., Ji, C.F., Shang, H.Y., Qiu, E.C., Wang, J.J., et al. (2010) Effect of Electroacupuncture on Cortical Spreading Depression and Plasma CGRP and Substance P Contents in Migraine Rats. Zhen Ci Yan Jiu, 35, 17-21.
[10] Tozzi, A., de Iure, A., Di Filippo, M., Costa, C., Caproni, S., Pisani, A., et al. (2012) Critical Role of Calcitonin Gene-Related Peptide Receptors in Cortical Spreading Depression. Proceedings of the National Academy of Sciences USA, 109, 18985-18990.
[11] Costa, C., Tozzi, A., Rainero, I., Cupini, L.M., Calabresi, P., Ayata, C., et al. (2013) Cortical Spreading Depression as a Target for Anti-Migraine Agents. Journal of Headache and Pain, 14, 62.
http://dx.doi.org/10.1186/1129-2377-14-62
[12] Chen, H.S. and Lipton, S.A. (2006) The Chemical Biology of Clinically Tolerated NMDA Receptor Antagonists. Journal of Neurochemistry, 97, 1611-1626.
http://dx.doi.org/10.1111/j.1471-4159.2006.03991.x
[13] Peeters, M., Gunthorpe, M.J., Strijbos, P.J., Goldsmith, P., Upton, N. and James, M.F. (2007) Effects of Pan- and Subtype-Selective N-Methyl-D-Aspartate Receptor Antagonists on Cortical Spreading Depression in the Rat: Therapeutic Potential for Migraine. Journal of Pharmacology and Experimental Therapeutics, 321, 564-572.
http://dx.doi.org/10.1124/jpet.106.117101
[14] Paoletti, P. and Neyton, J. (2007) NMDA Receptor Subunits: Function and Pharmacology. Current Opinion in Pharmacology, 7, 39-47.
http://dx.doi.org/10.1016/j.coph.2006.08.011
[15] Bigal, M., Rapoport, A., Sheftell, F., Tepper, D. and Tepper, S. (2008) Memantine in the Preventive Treatment of Refractory Migraine. Headache, 48, 1337-1342.
http://dx.doi.org/10.1111/j.1526-4610.2008.01083.x
[16] Krymchantowski, A. and Jevoux, C. (2009) Memantine in the Preventive Treatment for Migraine and Refractory Migraine. Headache, 49, 481-482.
http://dx.doi.org/10.1111/j.1526-4610.2009.01349.x
[17] Spengos, K., Theleritis, C. and Paparrigopoulos, T. (2008) Memantine and NMDA Antagonism for Chronic Migraine: A Potentially Novel Therapeutic Approach? Headache, 48, 284-286.
http://dx.doi.org/10.1111/j.1526-4610.2007.01016.x
[18] Wang, M., Li, Y. and Lin, Y. (2015) GABAA Receptor α2 Subtype Activation Suppresses Retinal Spreading Depression. Neuroscience, 298, 137-144.
http://dx.doi.org/10.1016/j.neuroscience.2015.04.016
[19] Ogden, K.K. and Traynelis, S.F. (2011) New Advances in NMDA Receptor Pharmacology. Trends in Pharmacological Sciences, 32, 726-733.
http://dx.doi.org/10.1016/j.tips.2011.08.003
[20] Wang, M., Chazot, P.L., Ali, S., Duckett, S.F. and Obrenovitch, T.P. (2012) Effects of NMDA Receptor Antagonists with Different Subtype Selectivities on Retinal Spreading Depression. British Journal of Pharmacology, 165, 235-244.
http://dx.doi.org/10.1111/j.1476-5381.2011.01553.x
[21] Shatillo, A., Salo, R.A., Giniatullin, R. and Grohn, O.H. (2015) Involvement of NMDA Receptor Subtypes in Cortical Spreading Depression in Rats Assessed by fMRI. Neuropharmacology, 93c, 164-170.
http://dx.doi.org/10.1016/j.neuropharm.2015.01.028
[22] Park, J.W., Suh, G.I., Shin, H.E. and Park, G.E. (2012) Influence of Memantine on Nociceptive Responses of the Trigeminocervical Complex after Formalin Injection. Cephalalgia, 32, 308-316.
http://dx.doi.org/10.1177/0333102411435986
[23] Kertesz, S., Kapus, G., Gacsalyi, I. and Levay, G. (2010) Deramciclane Improves Object Recognition in Rats: Potential Role of NMDA Receptors. Pharmacology Biochemistry & Behavior, 94, 570-574.
http://dx.doi.org/10.1016/j.pbb.2009.11.012

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.